Comparative Assessment of Efficacies Between 2 Alternative Therapeutic Sequences With Novel Androgen Receptor-Axis-Targeted Agents in Patients With Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer

Hideaki Miyake, Takuto Hara, Keita Tamura, +4

Clinical Genitourinary Cancer

Comparative AssessmentUrologyGenitourinary CancerMedicinePharmacology +7

Comparative Assessment of Clinical Outcomes Between Abiraterone Acetate and Enzalutamide in Patients With Docetaxel-Naive Metastatic Castration-Resistant Prostate Cancer: Experience in Real-World Clinical Practice in Japan

Hideaki Miyake, Takuto Hara, Tomoaki Terakawa, +2

Clinical Genitourinary Cancer

Comparative AssessmentUrologyOncologyReal-world Clinical PracticeGenitourinary Cancer +5

Real‐world sequential treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in Japan

Yuki Kita, Hikari Otsuka, Katsuhiro Ito, +17

International Journal of Urology

Presurgical Pazopanib Improves Surgical Outcomes for Renal Cell Carcinoma With High-level IVC Tumor Thrombosis

Yasuyoshi Okamura, Tomoaki Terakawa, Mariko Sakamoto, +8

In Vivo

An oral cancer vaccine using Bifidobacterium vector augments combination of anti-PD-1 and anti-CTLA-4 antibodies in mouse renal cell carcinoma model

Hideto Ueki, Koichi Kitagawa, Mako Kato, +9

Scientific Reports

Association between sarcopenia based on psoas muscle index and the response to nivolumab in metastatic renal cell carcinoma: A retrospective study

Hideto Ueki, Takuto Hara, Yasuyoshi Okamura, +6

Investigative and Clinical Urology

Expression pattern of immune checkpoint–associated molecules in radical nephrectomy specimens as a prognosticator in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors

Takuto Hara, Hideaki Miyake, Masato Fujisawa

Urologic Oncology Seminars and Original Investigations

UrologySurgical OncologyGenitourinary CancerMedicineExpression Pattern +7

Pathological complete response of renal cell carcinoma with vena cava tumor thrombus to neoadjuvant TKI/IO combination therapy

Takuto Hara, Tomoaki Terakawa, Toshiki Hyodo, +3

Urology Case Reports

Right Renal TumorSurgical OncologyVena CavaRenal PathologyImmunoediting +16

Impact of Prior Use of an Androgen Receptor-Axis-Targeted (ARAT) Agent With or Without Subsequent Taxane Therapy on the Efficacy of Another ARAT Agent in Patients With Metastatic Castration-Resistant Prostate Cancer

Hideaki Miyake, Takuto Hara, Seiichiro Ozono, +1

Clinical Genitourinary Cancer

UrologyArat AgentMedicinePrior UsePharmacology +6

Clinical Outcomes and Risk Stratification in Patients With Metastatic Hormone-Sensitive Prostate Cancer Treated With New-Generation Androgen Receptor Signaling Inhibitors

Kotaro Suzuki, Yusuke Shiraishi, Junya Furukawa, +10

Clinical Genitourinary Cancer

UrologyGenitourinary CancerMedicineCancer ManagementNew-generation Androgen Receptor +7